Current Products Retatrutide (10mg) PEP-007-10MG Metabolic Research CoA purity: 99.331% View CoA Retatrutide (20mg) PEP-024-20MG Metabolic Research CoA purity: 99.867% View CoA Melanotan II (10mg) PEP-009-10MG Melanocortin Agonists CoA purity: 99.873% View CoA Melanotan I (10mg) PEP-026-10MG Melanocortin Agonists CoA purity: 99.553% View CoA GLOW Peptide Blend (50mg) PEP-012-GLOW Tissue Repair Research CoA purity: N/A View CoA GLOW Peptide Blend (70mg) PEP-012-70MG Tissue Repair Research CoA purity: N/A View CoA KLOW Peptide Blend (80mg) PEP-031-KLOW Tissue Repair Research CoA purity: N/A View CoA BPC-157 (10mg) PEP-011-10MG Tissue Repair Research CoA purity: 99.765% View CoA Semax (10mg) PEP-008-10MG Nootropic Peptides CoA purity: 99.290% View CoA GHK-Cu (50mg) PEP-010-50MG Skin & Cellular Research CoA purity: 99.715% View CoA GHK-Cu (100mg) PEP-010-100MG Skin & Cellular Research CoA purity: 99.814% View CoA NAD+ (500mg) SUP-002-500MG Mitochondrial Research CoA purity: N/A View CoA Epitalon (10mg) PEP-027-10MG Skin & Cellular Research CoA purity: 98.426% View CoA SS-31 (10mg) PEP-020-10MG Mitochondrial Research CoA purity: 99.922% View CoA Tirzepatide (20mg) PEP-021-20MG Metabolic Research CoA purity: 99.595% View CoA Tirzepatide (40mg) PEP-021-40MG Metabolic Research CoA purity: 99.839% View CoA KPV (10mg) PEP-022-10MG Tissue Repair Research CoA purity: 99.234% View CoA Tesamorelin (10mg) PEP-030-10MG Metabolic Research CoA purity: 99.796% View CoA Ipamorelin (10mg) PEP-023-10MG Growth Hormone Research CoA purity: 99.686% View CoA Selank (10mg) PEP-013-10MG Nootropic Peptides CoA purity: 99.877% View CoA MOTS-C (10mg) PEP-014-10MG Mitochondrial Research CoA purity: 99.542% View CoA TB-500 (10mg) PEP-015-10MG Tissue Repair Research CoA purity: 97.712% View CoA CJC-1295 (no DAC) (10mg) PEP-016-10MG Growth Hormone Research CoA purity: 99.488% View CoA CJC-1295 (no DAC) + Ipamorelin (10mg) PEP-017-10MG Growth Hormone Research CoA purity: N/A View CoA BPC-157 + TB-500 (10mg) PEP-018-10MG Tissue Repair Research CoA purity: N/A View CoA Retatrutide (30mg) PEP-019-30MG Metabolic Research CoA purity: 99.882% View CoA Retatrutide (60mg) PEP-025-60MG Metabolic Research CoA purity: 99.834% View CoA PT-141 (10mg) PEP-035-10MG Melanocortin Agonists CoA purity: 99.896% View CoA DSIP (10mg) PEP-032-10MG Growth Hormone Research CoA purity: 99.002% View CoA MOTS-C (40mg) PEP-029-40MG Mitochondrial Research CoA purity: 99.647% View CoA ARA-290 (Cibinetide) (10mg) PEP-038-10MG Tissue Repair Research CoA purity: 99.67% View CoA Tirzepatide (60mg) PEP-021-60MG Metabolic Research CoA purity: Pending Request CoA Cagrilintide (5mg) PEP-039-5MG Metabolic Research CoA purity: Pending Request CoA Tesamorelin (20mg) PEP-028-20MG Metabolic Research CoA purity: Pending Request CoA CJC-1295 with DAC (10mg) PEP-003-10MG Growth Hormone Research CoA purity: Pending Request CoA MOTS-C (20mg) PEP-029-20MG Mitochondrial Research CoA purity: Pending Request CoA AOD-9604 (5mg) PEP-034-5MG Metabolic Research CoA purity: Pending Request CoA Glutathione (600mg) PEP-033-600MG Skin & Cellular Research CoA purity: Pending Request CoA Tesamorelin (5mg) PEP-036-5MG Metabolic Research CoA purity: Pending Request CoA Retatrutide (15mg) PEP-037-15MG Metabolic Research CoA purity: Pending Request CoA 5-Amino-1MQ (50mg) SUP-005-50MG Mitochondrial Research CoA purity: N/A Request CoA SLU-PP-332 (5mg) SUP-006-5MG Growth Hormone Research CoA purity: N/A Request CoA Need a Certificate of Analysis Now
Coming back to category one, the first round is going to have these seven peptides, bpc, tb, et cetera
Opitac Glutathione , developed by KOHJIN Life Sciences, Japan, is a premium, high-purity glutathione known for its skin-brightening and liver-supporting benefits
**Please note I am not a doctor or trained in the medical profession and cannot, and will not, make any diagnosis or confirmation of any medial condition
Studies have shown that the expression of the VRK2 gene is linked to depression risk, with its regulatory mechanisms demonstrating significant spatial specificity in affected individuals [311]
